The FDA approves remibrutinib for symptomatic dermographism, the first such therapy, extending an oral BTK inhibitor label via the Phase III RemIND trial.
|Articles|July 12, 2016
Crossflow Filter Device for Biotechnological Applications
Author(s)Pharmaceutical Technology Editors
The Sartocon Slice 50 crossflow filter device can be used for membrane screening and small-volume process development.
The Sartocon Slice 50 crossflow filter device from Sartorius Stedim Biotech (SSB) is designed for use in biotechnological applications, including membrane screening and small-volume process development. The device is offered as an encapsulated crossflow module with a filter area of 50 cm2 and a variety of molecular weight cutoffs. The crossflow filter eliminates the need for a compression holder and comes in a choice of two polymers:
- The Hydrosart membrane is a stable polymer suitable for a broad pH range and can be depyrogenated using sodium hydroxide at elevated temperatures. It is extremely hydrophilic, making it non-protein-binding and virtually non-fouling.
- The polyethersulfone membrane is a stable polymer that is ideal for a broad pH and temperature range.
The Sartocon Slice 50 is linearly scalable and be interfaced with SSB’s recently launched SARTOFLOW Smart benchtop crossflow system, as well as with many other laboratory-scale filtration systems.
Source: Sartorius Stedim Biotech
Related to this article
The company is showcasing new development solutions and advanced digital technologies including its new OSD Express and Steriles Express solutions for drug development.
Ron Scarboro, Azurity Pharmaceuticals, explains when formulation robustness justifies added cost and which post-approval quality and supply metrics teams can track.
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
Richard Jaenisch explains why NAMs are compressing drug development faster than AI and what FDA's new nonclinical testing rule means for sponsors.
Shadow AI and vendor data retention put GMP records and trade secrets at risk. AI Pulse Check panelists outline what pharma AI policies require.
Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.